We are live on
!
Find out more
VA
Vident Advisory Portfolio holdings
AUM
$11.7B
1-Year Est. Return
37.32%
This Fund
S&P 500
This Quarter
Est. Return
+13.81%
1 Year Est. Return
+37.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$1.56B
(+18%)
Cap. Flow
+$702M
Cap. Flow
% of AUM
6.71%
Top 10 Holdings %
Top 10 Hldgs %
20.79%
Holding
1,751
New
156
Increased
901
Reduced
550
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$31.6M |
| 2 |
Applovin
APP
|
+$29.6M |
| 3 |
Microsoft
MSFT
|
+$26M |
| 4 |
Fortinet
FTNT
|
+$24.6M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$21.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$37.5M |
| 2 |
CAE Inc. Common Shares
CAE
|
+$24.9M |
| 3 |
Salesforce
CRM
|
+$21.3M |
| 4 |
Iris Energy
IREN
|
+$20.9M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.63% |
| 2 | Industrials | 13.99% |
| 3 | Financials | 11.83% |
| 4 | Consumer Discretionary | 7.2% |
| 5 | Communication Services | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Royalty Pharma
RPRX
$26.1B
| $265K | ﹤0.01% |
7,518
+277
| +4% | +$10K |
|
|
ADAM
1452
Adamas Trust
ADAM
$777M
| $263K | ﹤0.01% |
37,723
+2,752
| +8% | +$19.1K |
|
1453
iShares US Home Construction ETF
ITB
$2.41B
| $262K | ﹤0.01% |
2,443
-178
| -7% | -$18.7K |
|
1454
Alerian MLP ETF
AMLP
$13B
| $261K | ﹤0.01% |
5,563
+1
| +0% | +$48 |
|
1455
Enpro
NPO
$7.05B
| $261K | ﹤0.01% |
+1,155
| New | +$249K |
|
|
FBRT
1456
Franklin BSP Realty Trust
FBRT
$601M
| $261K | ﹤0.01% |
+23,991
| New | +$264K |
|
1457
Neurocrine Biosciences
NBIX
$17.7B
| $260K | ﹤0.01% |
1,852
-29
| -2% | -$3.93K |
|
1458
Valaris
VAL
$5.51B
| $260K | ﹤0.01% |
5,326
-614
| -10% | -$29.9K |
|
1459
FNB Corp
FNB
$6.78B
| $259K | ﹤0.01% |
16,069
-298
| -2% | -$4.74K |
|
1460
Alcoa
AA
$11.7B
| $258K | ﹤0.01% |
7,842
+312
| +4% | +$9.7K |
|
|
BULL
1461
Webull Corp
BULL
$3.98B
| $257K | ﹤0.01% |
+17,402
| New | +$248K |
|
|
NREF
1462
NexPoint Real Estate Finance
NREF
$316M
| $257K | ﹤0.01% |
+18,120
| New | +$261K |
|
|
GTY
1463
Getty Realty Corp
GTY
$2.1B
| $257K | ﹤0.01% |
9,566
+1,498
| +19% | +$41.8K |
|
1464
UFP Industries
UFPI
$4.97B
| $255K | ﹤0.01% |
2,729
-262
| -9% | -$26.5K |
|
1465
Dimensional US Marketwide Value ETF
DFUV
$15.4B
| $255K | ﹤0.01% |
5,707
| – | – |
|
1466
Lincoln Electric
LECO
$13.8B
| $255K | ﹤0.01% |
1,081
-159
| -13% | -$37.2K |
|
1467
Organon & Co
OGN
$3.55B
| $255K | ﹤0.01% |
23,842
-4,237
| -15% | -$41.6K |
|
1468
iShares MBS ETF
MBB
$39B
| $254K | ﹤0.01% |
2,667
+62
| +2% | +$5.82K |
|
1469
StoneCo
STNE
$2.62B
| $254K | ﹤0.01% |
+13,418
| New | +$213K |
|
1470
Albertsons Companies
ACI
$5.4B
| $254K | ﹤0.01% |
14,484
-978
| -6% | -$19.2K |
|
1471
Choice Hotels
CHH
$5.03B
| $253K | ﹤0.01% |
2,371
-433
| -15% | -$52.9K |
|
1472
United Bankshares
UBSI
$6.55B
| $253K | ﹤0.01% |
6,806
-1,928
| -22% | -$71.9K |
|
|
BRSP
1473
BrightSpire Capital
BRSP
$681M
| $253K | ﹤0.01% |
+46,547
| New | +$253K |
|
1474
United Natural Foods
UNFI
$3.01B
| $251K | ﹤0.01% |
+6,683
| New | +$183K |
|
1475
Everest Group
EG
$15.2B
| $251K | ﹤0.01% |
717
-15
| -2% | -$5.06K |
|
Similar funds
HTC
BCI
VIA
NYLIM
PI
UE
LC
MG
Vident Advisory's Q3 2025 Portfolio in Review
As of Q3 2025, Vident Advisory held 1,751 positions worth $10.5B, up 18% from $8.91B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Vident Advisory deployed $702M of net new capital in Q3 2025, opening 156 new positions and adding to 901 existing holdings. Its largest new stake was IonQ: 256,676 shares worth $15.8M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Palantir, an estimated $37.5M trimmed.
- Vident Advisory's largest Q3 2025 buy was IonQ: 256,676 shares worth $15.8M.
- Vident Advisory added most to Northrop Grumman in Q3 2025, an estimated $31.6M increase.
- Vident Advisory's biggest Q3 2025 reduction was Palantir, cutting an estimated $37.5M.
- Vident Advisory fully exited Rapid7 in Q3 2025, selling an estimated $4.8M.
- Vident Advisory's ten largest holdings make up 21% of its $10.5B portfolio in Q3 2025.
- Vident Advisory opened 156 new positions and closed 119 in Q3 2025.
- Vident Advisory's portfolio value rose 18% quarter-over-quarter to $10.5B.
Based on Vident Advisory's 13F filing for Q3 2025, filed 14 Nov 2025.